BD Biotech Conference

Tue, Apr 2, 2013
Four Seasons Hotel
200 Boylston Street
Boston, MA 02116
(617) 338-4400

Cost: $1700 per person
Dress Code: Business Attire

The Boston Biotech Business Development Conference is a networking forum for industry professionals offering exclusive access to the key decision makers who influence deal making and investment in the life sciences. Attendees will gain insights from presentations and panels featuring business development decision-makers from several of the world\'s leading pharmaceutical and biotechnology companies, on the current and future outlook for licensing, M&A and other business development activities in the life sciences sector. In between learning what it takes to get a deal done in biotech, the Business Development Conference offers opportunities throughout the day to network one-on-one with the industry\'s top deal makers - senior executives from biotech and pharma, leaders from Wall Street and venture capitalists.

Past participants include:
• Ad Rawcliffe, S.V.P., Worldwide Business Development, GlaxoSmithKline
• Barbara Yanni, V.P. and Chief Licensing Officer, Merck
• Robert Bagdorf, Pfizer, VP, Business Development
• Merv Turner, SVP Worldwide Licensing and External Research
• John Maraganore, CEO, Alnylam
• David Pyott, CEO, Allergan
• Adelene Perkins, CEO Infinity Pharmaceuticals
• Bob Coughlin, President, Mass Biotech Council
• Chris Gabrieli, Co-founder and Chairman, Massachusetts 2020 Foundation
• Wyc Grousbeck, CEO and Owner, Boston Celtics
• JF Formela, Partner, Atlas Ventures

2012 Agenda
Time Agenda
7:00-7:30 am

Registration & Networking Breakfast

7:30-7:45 am

Welcome and Opening Remarks: Rich Aldrich, Michelle Dipp, Ashley Dombkowski, David Donabedian, Steve Engen, Robert Forrester, Jean George, Steven Holtzman, Neil Kirby, John Maraganore, Brian McVeigh, Mark Miller, Adelene Perkins, Laurence Reid, Jason Rhodes, James Sabry, Rick Shea, Christoph Westphal, Barbara Yanni

7:45-7:55 am

Keynote Speaker
Larry Summers, University Professor, Harvard (former President of Harvard, US Treasury Secretary)

7:55-8:00 am

Deleterious Me: Whole Genome Sequencing, 23andMe, and the Crowd-Sourced Health Care Revolution
Anne Wojcicki
, 23andMe

8:00-8:30 am

Mergers & Acquisitions
Drew Fromkin, former CEO, Clinical Data; Nick Galli, Genentech; Rajiv Kaul, Fidelity; Roger Sawhney, Novartis Pharma AG, Larry Wittenberg, Goodwin Proctor
Moderator: Jonathan Gertler, Back Bay Life Science Advisors

8:30-9:00 am

Large Biotech
Jim Frates, Alkermes; Steve Holtzman, Biogen; Tony Rosenberg, Novartis; Praveen Tipirneni, Cubist
Moderator: Mark Miller, Eli Lilly

9:00-9:30 am

Payors and Providers
Charlie Baker, General Catalyst; Kevin Tabb, Beth Israel Deaconess Medical Center
Moderator: Greg Pachus, Silicon Valley Bank

9:30-10:00 am

Small Biotech
Kees Been, EnVivo Pharma; Luc Dochez, Prosensa; Dan Paterson, Verastem; Duncan Higgons, Agios Pharmaceuticals; Jigar Raythatha, Constellation Pharmaceuticals
Moderator: Art Cook, ZS Associates

10:00-10:30 am

Networking Break

10:30-11:00 am

The West Coast Perspective
Juergen Lasowski, Onyx Pharmaceuticals; Jonathan Lim, City Hill Ventures; John Mendlein, aTyr Pharma
Moderator: Ashley Dombkowski, 23andme

11:00-11:30 am

Mid-size Biotech
Josh Hammermesh, Infinity; Julie McHugh, Endo Pharmaceuticals; Stu Randle, GI Dynamics; Laurence Reid, Alnylam; Rick Shea, Momenta
Moderator: Michelle Dipp, OvaScience

11:30-12:00 pm

Richard Eglen, Corning; Brian McVeigh, GlaxoSmithKline; Roger Pomerantz, Merck
Moderator: Rich Aldrich, Longwood Fund

12:00-12:30 pm

Rare Diseases
Bob Coughlin, Massachusetts Bio Council; Cyrus Mozayeni, Bluebird Bio; Deanna Petersen, Shire; Dan Regan, Inspiration Biopharmaceuticals
Moderator: Neil Kirby, Edimer Pharmaceuticals

12:30-1:00 pm

Networking Lunch

1:00-1:30 pm

Howard Furst, Deerfield Partners; Andrew Hatem, Fidelity Management & Research; Adam Koppel, Brookside Capital
Moderator: Mike King, Rodman & Renshaw

1:30-2:00 pm

Accessing Biotech and Academia
Jessie English, The Belfer Institute for Applied Cancer Science; David Sinclair, Department of Genetics, Harvard Medical School; Frank Stonebanks, Triphase
Moderator: Jon Pachter, Verastem

2:00-2:30 pm

European and Asian Perspectives
Christoph Boehringer, Mediatum and CD-Venture; Larry Cai, Medicilon; Philipp von Gallwitz, Grünenthal Group; John Oyler, BeiGene; David Phillips, SR One
Moderator: Rüdiger Herrmann, WilmerHale

2:30-3:00 pm

Networking Break

3:00-3:30 pm

Venture Capital
Bruce Booth, Atlas Venture; Jens Eckstein, SR One; Brian Halak, Domain Associates; Reid Leonard, Merck; Alan Walts, Genzyme Ventures
Moderator: Garheng Kong, Sofinnova Ventures

3:30-4:00 pm

New Directions in Pharma BD
Darren Carroll, Eli Lilly; Brian McVeigh, GlaxoSmithKline; Christopher Seaton, Bayer; Barbara Yanni, Merck
Moderator: Jeremy Goldberg, Torreya Partners

4:00-4:30 pm

Patient Perspectives
Mary Lynne Hedley, TESARO; Jason Rhodes, Epizyme; Carlo Russo, GlaxoSmithKline; Sameer Sabir, MoMelan Technologies
Moderator: Eileen Coveney, L.E.K. Consulting

4:30-5:00 pm

Changing Reimbursement Landscape
Mark Enyedy, Proteostasis Therapeutics; Jim Frates, Alkermes; Eric Grinstead, Synageva
Moderator: Peter Thompson, OrbiMed Advisors

5:00-5:30 pm

Structuring Deals: The Future
Rich Aldrich, Longwood Fund; Steve Bernitz, Extera Partners; David Donabedian, Locust Walk; Imran Eba, GlaxoSmithKline; James Geraghty, Genzyme
Moderator: David Redlick, WilmerHale

5:30-6:00 pm

Lifetime Achievement AwardCocktails and hors d'oeuvres
Nominees: Rich Aldrich, Duncan Higgons, David Schenkein

2012 Agenda
Time Agenda
7:15-8:00 am

Registration & Networking Breakfast

8:00-8:30 am

NY Biotech Initiative
Ron Cohen, Acorda Therapeutics; Mikael Dolsten, Pfizer; Greg Plowman, Eli Lilly; Marc Tessier-Lavigne, Rockefeller University
Moderator: Jean-Francois Formela, Atlas Ventures

8:30-8:45 am

Partnership Between FDA & Drug Development
Vicki Seyfert-Margolis, Office of the Commissioner, FDA

8:45-9:15 am

Biotechnology Industry Organization (BIO) Initiatives
Josh Boger, Founder Vertex; Jim Greenwood, BIO

9:15-10:00 am


10:00-2:00 pm

Two Concurrent Workshops (see full agendas below)

Orphan Drug Summit (Oriental Ballroom)

Fertility Summit (Bangkok Room)

2:00-3:00 pm

Wine and cheese

Orphan Drug Summit
Time Agenda
10:00-10:45 am

Orphan Drug Development and Regulation: Abbie Celniker, Eleven Biotherapeutics; Nick Leschly, Bluebird Bio; Arthur Tzianabos, Shire; Tim Cote, NORD
Moderator: Neil Kirby, Edimer Pharmaceuticals

10:45-11:30 am

Orphan Drug Company Strategies: JC Gutierrez-Ramos, Pfizer; Claudia Hirawat, PTC Therapeutics
Moderator: Mike Gilman, Stromedix

11:30-12:20 pm Networking Lunch
12:20-1:05 pm

Business Development and Role of VC in Orphan Drug Development: Ashley Dombkowski, 23andMe; Alan Walts, Genzyme Ventures; Christoph Westphal, Verastem
Moderator: John Ripple, Ripple Biotech

1:05-1:15 pm

Patient Associations: Tim Cote, NORD

1:15-2:00 pm

Commercial Strategies: Chris Adams, Formerly FoldRx/Pfizer; Tony Rosenberg, Novartis; Barry Frankel, Frankel Group
Moderator: Barbara Deptula, Shire

2:00-3:00 pm Wine and Cheese
Fertility Summit
Time Agenda
10:00-10:45 am

10:00 - 10:25 am Bioenergetics in IVF: David Sable, Special Situations Life Sciences Fund
10:25 - 10:45 am The Role of Mitochondria in Fertility: Robert Casper, University of Toronto
Moderator: Christopher Bleck, OvaScience

10:45-11:30 am

New Advances in Fertility Treatment: Benjamin Leader, ReproSource, Inc.; Alan Penzias, Harvard Medical School, BIDMC, Boston IVF; Mitchell Rosen, University of California, San Francisco
Moderator: Thomas Toth, Mass General Hospital & Harvard Medical School

11:30-12:30 pm Networking Lunch
12:30-1:15 pm

Fertility and Aging: Jonathan Tilly, MGH & Harvard Medical School; David Sinclair, Harvard Medical School
Moderator: Scott Chappel, OvaScience

1:15-2:00 pm

Patient Advocacy: Barbara Collura, RESOLVE: The National Infertility Association; Erin Lasker, RESOLVE New England
Moderator: Michelle Dipp, OvaScience

2:00-3:00 pm Wine and Cheese


Name Address Phone
Four Seasons Hotel Boston 200 Boylston Street, Boston, MA 02116 (617) 351-2036


Name Company
Rich Aldrich
Michelle Dipp
Ashley Dombkowski
David Donabedian
Steve Engen
Robert Forrester
Jean George
Steven Holtzman
Neil Kirby
Jeffrey Leiden
John Maraganore
Brian McVeigh
Mark Miller
Adelene Perkins
Laurence Reid
Jason Rhodes
James Sabry
Rick Shea
Christoph Westphal